CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,134,430 | -36.0% | 92,200 | -27.5% | 0.36% | -50.1% |
| Q4 2022 | $3,332,640 | -68.3% | 127,200 | -76.2% | 0.72% | -51.0% |
| Q3 2022 | $10,505,000 | -6.7% | 534,358 | -17.0% | 1.46% | +21.1% |
| Q2 2022 | $11,259,000 | +39.4% | 643,731 | +30.4% | 1.20% | +5.4% |
| Q1 2022 | $8,077,000 | +343.5% | 493,677 | +342.2% | 1.14% | +471.0% |
| Q4 2021 | $1,821,000 | +15.3% | 111,653 | +9.8% | 0.20% | +65.3% |
| Q1 2021 | $1,580,000 | -50.6% | 101,666 | -49.6% | 0.12% | -57.4% |
| Q4 2020 | $3,198,000 | – | 201,666 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |